Sei Investments CO Lexicon Pharmaceuticals, Inc. Transaction History

Sei Investments CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 08, 2021	SELL	$1.05 - $3.67 $153,321 - $535,893	-146,020 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$1.75 - $2.3 $255,535 - $335,846	146,020 New	146,020 $291,000
Q3 2018 Nov 08, 2018	SELL	$10.32 - $13.06 $753 - $953	-73 Closed	0 $0
Q2 2018 Aug 03, 2018	SELL	$7.8 - $13.69 $912 - $1,601	-117 Reduced 61.58%	73 $1,000
Q1 2018 May 11, 2018	BUY	$7.86 - $11.39 $1,139 - $1,651	145 Added 322.22%	190 $1,000

Q3 2017 Nov 06, 2017	BUY	$12.17 - $16.3 $547 - $733	45	45 $1,000

122

159M

2.11M

412K

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $302M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

Stay updated on Sei Investments CO with notifications on news.